Kbc Group Nv Ardelyx, Inc. Transaction History
Kbc Group Nv
- $37 Billion
- Q2 2025
A detailed history of Kbc Group Nv transactions in Ardelyx, Inc. stock. As of the latest transaction made, Kbc Group Nv holds 4,929 shares of ARDX stock, worth $28,933. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,929
Previous 13,706
64.04%
Holding current value
$28,933
Previous $67,000
71.64%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ARDX
# of Institutions
244Shares Held
161MCall Options Held
697KPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA18.4MShares$108 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$103 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X013.8MShares$81.1 Million0.04% of portfolio
-
Macquarie Group LTD Australia, C310.5MShares$61.4 Million0.07% of portfolio
-
State Street Corp Boston, MA9.72MShares$57 Million0.0% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $908M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...